CNBX Pharmaceuticals Inc. (CNBX) Shares Outstanding (2011 - 2026)

CNBX Pharmaceuticals (CNBX) has 16 years of Shares Outstanding (Entity) data on file, last reported at $1.5 billion in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 3364.46% year-over-year to $1.5 billion in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.5 billion (up 3364.46% YoY) and the FY2025 annual result came in at $90.6 million, up 191.37% from the prior year.
• Shares Outstanding (Entity) grew to $1.5 billion in Q2 2026, from $931.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.5 billion in Q2 2026 to a low of $1.2 million in Q3 2022.
• A 5-year average of $202.8 million and a median of $31.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) plunged 99.21% — and 2026, when it surged 3364.46%.
• Tracing CNBX's Shares Outstanding (Entity) over 5 years: stood at $1.2 million in 2022, then jumped by 2185.65% to $28.3 million in 2023, then rose by 9.89% to $31.1 million in 2024, then jumped by 2320.97% to $753.2 million in 2025, then jumped by 95.93% to $1.5 billion in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.5 billion (Q2 2026), $931.0 million (Q1 2026), and $753.2 million (Q4 2025), per Business Quant data.